T-Cypher Bio
PrivateLast Round
Seed
Feb 25, 2021
Total Funding Raised
$42.3M
Company Overview
T-Cypher Bio is a biotechnology company that develops a pipeline of novel, T-cell receptor (TCR)-based therapeutics for solid tumours, autoimmune, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-Cypher Bio Comparables
Compare T-Cypher Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T-Therapeutics | 88% | |
| Engimmune Therapeutics | 86% | |
| Enara Bio | 86% |
T-Cypher Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 25, 2021 | ||||
| Series A | Feb 25, 2021 |
Key People
Founding team and executive leadership
T-Cypher Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Series A, Seed |
| University of Oxford | Series A, Seed |
| Borealis Ventures | Series A, Seed |
| Rio Tinto Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2024
Grew 20% QoQ, from 25 to 30 employees.
- Apr 12, 2024
Grew 30% QoQ, from 23 to 30 employees.
T-Cypher Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about T-Cypher Bio's valuation, stock price, and market status.
Is T-Cypher Bio a public or private company?
T-Cypher Bio is a private company.
What is the current stock price of T-Cypher Bio?
T-Cypher Bio is a private company with no public stock price. No recent secondary market data is available.
How much is T-Cypher Bio worth (valuation)?
Valuation information for T-Cypher Bio is not publicly available.
Can I buy T-Cypher Bio stock?
T-Cypher Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was T-Cypher Bio's last funding round?
T-Cypher Bio's most recent funding round was Seed on February 25, 2021.
Who are the main investors in T-Cypher Bio?
Key investors in T-Cypher Bio include Oxford Science Enterprises.
Will T-Cypher Bio IPO soon?
No public IPO plans have been announced for T-Cypher Bio.
How can I track T-Cypher Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor T-Cypher Bio's secondary market activity and sign up for updates.